Network Meta-Analysis of the Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comparison of Annual Moderate and Severe Exacerbations

被引：0
|
作者：
Ismaila, A. S. [1 ]
Haeussler, K. [2 ]
Czira, A. [3 ]
Youn, J. [4 ]
Malmenas, M. [5 ]
Risebrough, N. [6 ]
Agarwal, J. [7 ]
Nassim, M.
Sharma, R. [3 ]
Compton, C. [3 ]
Vogelmeier, C. F. [8 ]
Halpin, D. M. G. [9 ]
机构：
[1] GlaxoSmithKline, R&D Global Med, Collegeville, PA USA
[2] ICON plc, Munich, Germany
[3] GlaxoSmithKline, R&D Global Med, Brentford, England
[4] ICON plc, London, England
[5] ICON plc, Stockholm, Sweden
[6] ICON plc, Burlington, ON, Canada
[7] ICON plc, Bangalore, Karnataka, India
[8] Philipps Univ Marburg, Univ Med Ctr Giessen & Marburg, Dept Med, Pulm & Crit Care Med, Marburg, Germany
[9] Univ Exeter, Univ Exeter Med Sch, Coll Med & Hlth, Exeter, Devon, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1454
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Network Meta-analysis (NMA) of the Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Compared with other Triple Therapies for the Treatment of chronic obstructive Pulmonary Disease (COPD): A Comparison of annualized Rates of moderate and severe Exacerbations
    Ismaila, A.
    Haeussler, K.
    Czira, A.
    Youn, J.
    Malmenaes, M.
    Risebrough, N.
    Nassim, M.
    Sharma, R.
    Compton, C.
    Vogelmeier, C.
    Halpin, D.
    PNEUMOLOGIE, 2023, 77 : S96 - S96
  • [2] Comparative Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review and Network Meta-Analysis
    Ismaila, A. S.
    Haeussler, K.
    Czira, A.
    Youn, J.
    Malmenas, M.
    Risebrough, N.
    Agarwal, J.
    Nassim, M.
    Sharma, R.
    Compton, C.
    Vogelmeier, C. F.
    Halpin, D. M. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis
    Afisi S. Ismaila
    Katrin Haeussler
    Alexandrosz Czira
    Ji-Hee Youn
    Mia Malmenäs
    Nancy A. Risebrough
    Jatin Agarwal
    Maria Nassim
    Raj Sharma
    Chris Compton
    Claus F. Vogelmeier
    MeiLan K. Han
    David M. G. Halpin
    Advances in Therapy, 2022, 39 : 3957 - 3978
  • [4] Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis
    Ismaila, Afisi S.
    Haeussler, Katrin
    Czira, Alexandrosz
    Youn, Ji-Hee
    Malmenas, Mia
    Risebrough, Nancy A.
    Agarwal, Jatin
    Nassim, Maria
    Sharma, Raj
    Compton, Chris
    Vogelmeier, Claus F.
    Han, MeiLan K.
    Halpin, David M. G.
    ADVANCES IN THERAPY, 2022, 39 (09) : 3957 - 3978
  • [5] Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis”
    Jonathan Marshall
    Akanksha Sharma
    Patrick Darken
    Mario Ouwens
    Barinder Singh
    Deniz Tansey-Dwyer
    Advances in Therapy, 2023, 40 : 2549 - 2555
  • [6] Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis"
    Marshall, Jonathan
    Sharma, Akanksha
    Darken, Patrick
    Ouwens, Mario
    Singh, Barinder
    Tansey-Dwyer, Deniz
    ADVANCES IN THERAPY, 2023, 40 (05) : 2549 - 2555
  • [7] A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”
    Afisi S. Ismaila
    Katrin Haeussler
    Mia Malmenäs
    Raj Sharma
    Chris Compton
    Claus F. Vogelmeier
    MeiLan K. Han
    David M. G. Halpin
    Advances in Therapy, 2023, 40 : 2556 - 2561
  • [8] A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"
    Ismaila, Afisi S.
    Haeussler, Katrin
    Malmenas, Mia
    Sharma, Raj
    Compton, Chris
    Vogelmeier, Claus F.
    Han, MeiLan K.
    Halpin, David M. G.
    ADVANCES IN THERAPY, 2023, 40 (05) : 2556 - 2561
  • [9] Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC plus FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials
    Hanania, Nicola A.
    Caveney, Scott
    Soule, Tedi
    Tombs, Lee
    Lettis, Sally
    Crim, Courtney
    Mannino, David M.
    Patel, Hitesh
    Boucot, Isabelle H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1925 - 1938
  • [10] Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
    Sandeep Bansal
    Martin Anderson
    Antonio Anzueto
    Nicola Brown
    Chris Compton
    Thomas C. Corbridge
    David Erb
    Catherine Harvey
    Morrys C. Kaisermann
    Mitchell Kaye
    David A. Lipson
    Neil Martin
    Chang-Qing Zhu
    Alberto Papi
    npj Primary Care Respiratory Medicine, 31
12345